Trijardy XR 5 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 5 mg/1

Trijardy XR 5 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control and is suitable for adults.

Strength

5 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 5 mg/1 is designed to help manage type 2 diabetes by improving blood sugar levels. It combines three active ingredients: empagliflozin, which promotes glucose excretion through urine; linagliptin, which enhances insulin production; and metformin hydrochloride, which reduces glucose production in the liver. This combination therapy is often used when diet and exercise alone are not sufficient for controlling blood sugar levels.

Side Effects

Common effects of Trijardy XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

Trijardy XR 5 mg/1 should be taken as directed by a healthcare provider. It is important to stay hydrated and monitor blood sugar levels regularly. Patients with kidney problems, a history of pancreatitis, or those taking other diabetes medications should discuss potential risks with their healthcare provider before starting this medication.

Avoid Interactions

Trijardy XR 5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be limited, as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Trijardy XR 5 mg/1 is used to manage type 2 diabetes by improving blood sugar control through a combination of empagliflozin, linagliptin, and metformin hydrochloride.

Trijardy XR 5 mg/1 should be taken orally, typically once daily, with food. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and hypoglycemia. These effects vary among individuals.

Trijardy XR 5 mg/1 may interact with other diabetes medications. Consult your healthcare provider before combining it with other treatments.

Trijardy XR 5 mg/1 is not suitable for everyone. Patients with certain medical conditions or those taking specific medications should discuss its use with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.